The Conceptualization of Value in the Value Proposition of New Health Technologies Comment on "Providing Value to New Health Technology: The Early Contribution of Entrepreneurs, Investors, and Regulatory Agencies"

被引:3
|
作者
Buttigieg, Sandra C. [1 ,2 ]
van Hoof, Joost [3 ]
机构
[1] Univ Malta, Fac Hlth Sci, Msida, Malta
[2] Univ Birmingham, Sch Social Policy, Coll Social Sci, Birmingham, W Midlands, England
[3] Fontys Univ Appl Sci, Inst Allied Hlth Profess, Eindhoven, Netherlands
关键词
Conceptualisation of Value; New Technology; Innovations; Stakeholder Analysis; CARE ENVIRONMENTS; DESIGN;
D O I
10.15171/ijhpm.2017.75
中图分类号
R19 [保健组织与事业(卫生事业管理)];
学科分类号
摘要
Lehoux et al provide a highly valid contribution in conceptualizing value in value propositions for new health technologies and developing an analytic framework that illustrates the interplay between health innovation supply-side logic (the logic of emergence) and demand-side logic (embedding in the healthcare system). This commentary brings forth several considerations on this article. First, a detailed stakeholder analysis provides the necessary premonition of potential hurdles in the development, implementation and dissemination of a new technology. This can be achieved by categorizing potential stakeholder groups on the basis of the potential impact of future technology. Secondly, the conceptualization of value in value propositions of new technologies should not only embrace business/economic and clinical values but also ethical, professional and cultural values, as well as factoring in the notion of usability and acceptance of new technology. As a final note, the commentary emphasises the point that technology should facilitate delivery of care without negatively affecting doctorpatient communications, physical examination skills, and development of clinical knowledge.
引用
收藏
页码:186 / 188
页数:3
相关论文
共 50 条
  • [1] New Health Technologies: A UK Perspective Comment on "Providing Value to New Health Technology: The Early Contribution of Entrepreneurs, Investors, and Regulatory Agencies"
    Parvizi, Nassim
    Parvizi, Sahar
    [J]. INTERNATIONAL JOURNAL OF HEALTH POLICY AND MANAGEMENT, 2017, 6 (12): : 721 - 722
  • [2] Providing Value to New Health Technology: The Early Contribution of Entrepreneurs, Investors, and Regulatory Agencies
    Lehoux, Pascale
    Miller, Fiona A.
    Daudelin, Genevieve
    Denis, Jean-Louis
    [J]. INTERNATIONAL JOURNAL OF HEALTH POLICY AND MANAGEMENT, 2017, 6 (09): : 509 - 518
  • [3] The political economy of the assessment of value of new health technologies
    Karnon, Jonathan
    Edney, Laura
    Afzali, Hossein
    [J]. JOURNAL OF HEALTH SERVICES RESEARCH & POLICY, 2018, 23 (02) : 116 - 122
  • [4] E-Health: Value Proposition and Technologies Enabling Collaborative Healthcare
    Sneha, Sweta
    Straub, Detmar
    [J]. PROCEEDINGS OF THE 50TH ANNUAL HAWAII INTERNATIONAL CONFERENCE ON SYSTEM SCIENCES, 2017, : 920 - 929
  • [5] Value of Research and Value of Development in Early Assessments of New Medical Technologies
    Retel, Valesca P.
    Grutters, Janneke P. C.
    van Harten, Wim H.
    Joore, Manuela A.
    [J]. VALUE IN HEALTH, 2013, 16 (05) : 720 - 728
  • [6] The Value Proposition for a Long Term Care Contribution to an Academic Health Care System
    Campbell, J.
    Rader, E.
    Rielinger, J.
    Bhansali, J.
    Saref, J.
    Zhang, M.
    Gupta, N.
    Wu, Z.
    [J]. JOURNAL OF THE AMERICAN GERIATRICS SOCIETY, 2010, 58 : 225 - 225
  • [7] Role for Health Technology Agencies in Assessment of New Cancer Technologies
    Boudreau, R.
    [J]. EUROPEAN JOURNAL OF CANCER, 2011, 47 : S42 - S42
  • [8] The Value of New: Consideration of Product Novelty in Health Technology Assessments of Pharmaceuticals
    Patricia G. Synnott
    Dominic Voehler
    Daniel E. Enright
    Stacey Kowal
    Daniel A. Ollendorf
    [J]. Applied Health Economics and Health Policy, 2023, 21 : 305 - 314
  • [9] The Value of New: Consideration of Product Novelty in Health Technology Assessments of Pharmaceuticals
    Synnott, Patricia G. G.
    Voehler, Dominic
    Enright, Daniel E. E.
    Kowal, Stacey
    Ollendorf, Daniel A. A.
    [J]. APPLIED HEALTH ECONOMICS AND HEALTH POLICY, 2023, 21 (02) : 305 - 314
  • [10] ALIGNING VALUE IN REGULATORY REVIEW, PRACTICE PATHWAYS, AND HEALTH TECHNOLOGY ASSESSMENT
    Garrison, L.
    Towse, A.
    [J]. VALUE IN HEALTH, 2019, 22 : S164 - S164